31,395 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Lloyd Advisory Services LLC.

Lloyd Advisory Services LLC. acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 1st quarter, Holdings Channel reports. The fund acquired 31,395 shares of the pharmacy operator’s stock, valued at approximately $681,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. QRG Capital Management Inc. acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth $383,000. Dark Forest Capital Management LP lifted its position in shares of Walgreens Boots Alliance by 6.5% in the third quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after buying an additional 1,804 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its position in Walgreens Boots Alliance by 21.6% during the third quarter. Cary Street Partners Investment Advisory LLC now owns 23,417 shares of the pharmacy operator’s stock worth $521,000 after purchasing an additional 4,166 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $5,494,000. Finally, Natixis Advisors L.P. boosted its holdings in Walgreens Boots Alliance by 268.4% during the third quarter. Natixis Advisors L.P. now owns 184,722 shares of the pharmacy operator’s stock valued at $4,108,000 after acquiring an additional 134,587 shares during the period. 58.59% of the stock is owned by institutional investors.

Analysts Set New Price Targets

WBA has been the topic of several research analyst reports. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Truist Financial restated a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. UBS Group dropped their price objective on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday. Finally, Morgan Stanley cut their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating on the stock in a research report on Friday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $23.07.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $15.91 on Tuesday. Walgreens Boots Alliance, Inc. has a 52-week low of $14.62 and a 52-week high of $31.88. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a 50 day simple moving average of $16.80 and a 200 day simple moving average of $20.41.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.16 earnings per share. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.29%. Walgreens Boots Alliance’s dividend payout ratio is -14.29%.

Insider Activity

In related news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.